Fatih Tunca

Prof. Dr. Fatih Tunca


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2017 in CardioVascular and Interventional Radiology
Verified
Journal Article
Closed access
PDF file
İSİsmail Cem Sormaz
İsmail Cem Sormaz
APArzu Poyanlı
Arzu Poyanlı
SASami Açar
Sami Açar
AİAhmet Yalın İşcan
Ahmet Yalın İşcan
IOİlKer Ozgur
İlKer Ozgur
YSYasemin Giles Senyürek
Yasemin Giles Senyürek

15 July 2011 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
FTFatih Tunca
Fatih Tunca
YSYasemin Giles Senyurek
Yasemin Giles Senyurek
TTTarik Terzioglu
Tarik Terzioglu
YIYalın Iscan
Yalın Iscan
STSerdar Tezelman
Serdar Tezelman

1 December 2007 in Surgery
Verified
Journal Article
Closed access
FTFatih Tunca
Fatih Tunca
YGY. Giles
Y. Giles
ASA. Salmaslioglu
A. Salmaslioglu
APA. Poyanli
A. Poyanli
DYD. Yılmazbayhan
D. Yılmazbayhan
STS. Tezelman
S. Tezelman

18 August 2015 in Journal of Endocrinological Investigation
Verified
Journal Article
Closed access
PDF file
FTFatih Tunca
Fatih Tunca
ISI. C. Sormaz
I. C. Sormaz
YIY. Iscan
Y. Iscan
YSY. G. Senyurek
Y. G. Senyurek
TTT. Terzioglu
T. Terzioglu

29 July 2018 in Turkish Journal of Surgery
Verified
Journal Article
Open access
PDF file
OMOzer Makay
Ozer Makay
MOMurat Ozdemir
Murat Ozdemir
YSYasemin Giles Senyurek
Yasemin Giles Senyurek
FTFatih Tunca
Fatih Tunca
MDMete Duren
Mete Duren
STSerdar Tezelman
Serdar Tezelman
Objectives: The incidence of papillary microcarcinomas, which are defined as thyroid cancers of <10mm in size, has been increasing in the last decade. Herein, we present internet-based questionnaire results performed by the Turkish Association of Endocrine Surgery with the aim to evaluate the perspective of the management of papillary microcarcinomas in Turkey. Material and Methods: The user-friendly questionnaire consisted of 13 questions in total. These questions mainly addressed the surgical management of nodules and cancer of <1 cm in size. Patient management before, during, and after surgical intervention was also included; additionally, the "active surveillance approach" was questioned. Results: There were 420 responders in total who were of multidisciplinary origin (endocrinologists, surgeons, nuclear medicine specialists, pathologists, and oncologists). Total thyroidectomy was the predominant treatment approach (65%) for the classical type of microcarcinoma limited in one lobe, whereas in cases of microcarcinomas incidentally diagnosed during hemithyroidectomy, complementary surgery approach was advised by 40% of the responders. The responders found capsule invasion (86%) and patient based management (94%) of high importance. The percentage of the responders who recommended radioactive iodine ablation in incidental cancers having no aggressive criteria was 51%. The survey participants that were against routine central dissection in these cases accounted for 73% of the responders. The recommendation of active surveillance (follow-up without any interventional therapy) was limited with 9% responders. Conclusion: The results of the questionnaire demonstrated that there have been various choices in Turkey for the surgical treatment of the papillary microcarcinomas.